These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8412017)

  • 1. Canavan disease: biochemical and molecular studies.
    Matalon R; Kaul R; Michals K
    J Inherit Metab Dis; 1993; 16(4):744-52. PubMed ID: 8412017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canavan disease: diagnosis and molecular analysis.
    Matalon R
    Genet Test; 1997; 1(1):21-5. PubMed ID: 10464621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spongy degeneration of the brain, Canavan disease: biochemical and molecular findings.
    Matalon RM; Michals-Matalon K
    Front Biosci; 2000 Mar; 5():D307-11. PubMed ID: 10704428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease.
    Kaul R; Gao GP; Balamurugan K; Matalon R
    Nat Genet; 1993 Oct; 5(2):118-23. PubMed ID: 8252036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal detection of Canavan disease (aspartoacylase deficiency) by DNA analysis.
    Elpeleg ON; Shaag A; Anikster Y; Jakobs C
    J Inherit Metab Dis; 1994; 17(6):664-6. PubMed ID: 7707689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.
    Matalon R; Michals K; Sebesta D; Deanching M; Gashkoff P; Casanova J
    Am J Med Genet; 1988 Feb; 29(2):463-71. PubMed ID: 3354621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canavan disease: from spongy degeneration to molecular analysis.
    Matalon R; Michals K; Kaul R
    J Pediatr; 1995 Oct; 127(4):511-7. PubMed ID: 7562269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemistry and molecular biology of Canavan disease.
    Matalon R; Michals-Matalon K
    Neurochem Res; 1999 Apr; 24(4):507-13. PubMed ID: 10227683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of Canavan's disease: from human to mouse.
    Surendran S; Matalon KM; Tyring SK; Matalon R
    J Child Neurol; 2003 Sep; 18(9):604-10. PubMed ID: 14572138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canavan disease: a monogenic trait with complex genomic interaction.
    Surendran S; Michals-Matalon K; Quast MJ; Tyring SK; Wei J; Ezell EL; Matalon R
    Mol Genet Metab; 2003; 80(1-2):74-80. PubMed ID: 14567959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliable prenatal diagnosis of Canavan disease by measuring N-acetylaspartate in amniotic fluid using liquid chromatography tandem mass spectrometry.
    Al-Dirbashi OY; Kurdi W; Imtiaz F; Ahmad AM; Al-Sayed M; Tulbah M; Al-Nemer M; Rashed MS
    Prenat Diagn; 2009 May; 29(5):477-80. PubMed ID: 19235826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliable prenatal diagnosis of Canavan disease (aspartoacylase deficiency): comparison of enzymatic and metabolite analysis.
    Bennett MJ; Gibson KM; Sherwood WG; Divry P; Rolland MO; Elpeleg ON; Rinaldo P; Jakobs C
    J Inherit Metab Dis; 1993; 16(5):831-6. PubMed ID: 8295397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canavan disease prenatal diagnosis and genetic counseling.
    Matalon R; Matalon KM
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):297-304. PubMed ID: 12108830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel aspartoacylase (ASPA) gene mutation in Canavan disease.
    Durmaz AA; Akin H; Onay H; Vahabi A; Ozkinay F
    Fetal Pediatr Pathol; 2012 Aug; 31(4):236-9. PubMed ID: 22468686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel splice site mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
    Rady PL; Penzien JM; Vargas T; Tyring SK; Matalon R
    Eur J Paediatr Neurol; 2000; 4(1):27-30. PubMed ID: 10701101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease.
    Kaul R; Gao GP; Matalon R; Aloya M; Su Q; Jin M; Johnson AB; Schutgens RB; Clarke JT
    Am J Hum Genet; 1996 Jul; 59(1):95-102. PubMed ID: 8659549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.
    Zeng BJ; Wang ZH; Ribeiro LA; Leone P; De Gasperi R; Kim SJ; Raghavan S; Ong E; Pastores GM; Kolodny EH
    J Inherit Metab Dis; 2002 Nov; 25(7):557-70. PubMed ID: 12638939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution.
    Kaul R; Balamurugan K; Gao GP; Matalon R
    Genomics; 1994 May; 21(2):364-70. PubMed ID: 8088831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canavan disease: a review of recent developments.
    Gordon N
    Eur J Paediatr Neurol; 2001; 5(2):65-9. PubMed ID: 11589315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Canavan disease with microcephaly.
    Gowda VK; Bhat MD; Srinivasan VM; Prasad C; Benakappa A; Faruq M
    Brain Dev; 2016 Sep; 38(8):759-62. PubMed ID: 26992473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.